NEOGENOMICS INC — Director's Dealing 2022

Jun 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-06-10

Reporting Person: Kelly Michael Aaron (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-10	Common Stock	A	15556	—	Acquired	20419	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-10	Stock Option (Right to Buy)	$8.1	A	13882	Acquired	2029-06-10	Common Stock (13882.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$37.53	2027-05-28	Common Stock (2223.0)	2223	Direct
Stock Option (Right to Buy)	$40.9	2028-06-02	Common Stock (3714.0)	3714	Direct